The role of lipids in the pathophysiology of coronavirus infections

다국어 초록 (Multilingual Abstract)

Coronaviruses, which have been known to cause diseases in animals since the 1930s, utilize cellular components during their replication cycle. Lipids play important roles in viral infection, as coronaviruses target cellular lipids and lipid metabolism to modify their host cells to become an optimal environment for viral replication. Therefore, lipids can be considered as potential targets for the development of antiviral agents. This review provides an overview of the roles of cellular lipids in different stages of the life cycle of coronaviruses.

참고문헌 (Reference)

1 de Castro IF, "Virus factories : biogenesis and structural design" 15 : 24-34, 2013

2 Chazal N, "Virus entry, assembly, budding, and membrane rafts" 67 : 226-237, 2003

3 Hsu NY, "Viral reorganization of the secretory pathway generates distinct organelles for RNA replication" 141 : 799-811, 2010

4 Thaker SK, "Viral hijacking of cellular metabolism" 17 : 59-, 2019

5 Snijder EJ, "Ultrastructure and origin of membrane vesicles associated with the severe acute respiratory syndrome coronavirus replication complex" 80 : 5927-5940, 2006

6 Guo H, "The important role of lipid raft-mediated attachment in the infection of cultured cells by coronavirus infectious bronchitis virus Beaudette strain" 12 : e0170123-, 2017

7 de Haan CA, "The glycosylation status of the murine hepatitis coronavirus M protein affects the interferogenic capacity of the virus in vitro and its ability to replicate in the liver but not the brain" 312 : 395-406, 2003

8 Hansen GH, "The coronavirus transmissible gastroenteritis virus causes infection after receptormediated endocytosis and acid-dependent fusion with an intracellular compartment" 72 : 527-534, 1998

9 McBride R, "The coronavirus nucleocapsid is a multifunctional protein" 6 : 2991-3018, 2014

10 Hui DS, "The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health : the latest 2019 novel coronavirus outbreak in Wuhan, China" 91 : 264-266, 2020

11 Diamond DL, "Temporal proteome and lipidome profiles reveal hepatitis C virus-associated reprogramming of hepatocellular metabolism and bioenergetics" 6 : e1000719-, 2010

12 Yang N, "Targeting the endocytic pathway and autophagy process as a novel therapeutic strategy in COVID-19" 16 : 1724-1731, 2020

13 Fernandez-Oliva A, "Targeting host lipid flows : exploring new antiviral and antibiotic strategies" 21 : e12996-, 2019

14 Kraft ML, "Sphingolipid organization in the plasma membrane and the mechanisms that influence it" 4 : 154-, 2017

15 Bermingham A, "Severe respiratory illness caused by a novel coronavirus, in a patient transferred to the United Kingdom from the Middle East, September 2012" 17 : 20290-, 2012

16 Bosch BJ, "Severe acute respiratory syndrome coronavirus(SARS-CoV)infection inhibition using spike protein heptad repeat-derived peptides" 101 : 8455-8460, 2004

17 Angelini MM, "Severe acute respiratory syndrome coronavirus nonstructural proteins 3, 4, and 6induce double-membrane vesicles" 4 : e00524-13, 2013

18 Wang H, "SARS coronavirus entry into host cells through a novel clathrin-and caveolae-independent endocytic pathway" 18 : 290-301, 2008

19 Pratelli A, "Role of the lipid rafts in the life cycle of canine coronavirus" 96 (96): 331-337, 2015

20 Sun X, "Role for influenza virus envelope cholesterol in virus entry and infection" 77 : 12543-12551, 2003

21 Grassme H, "Rhinoviruses infect human epithelial cells via ceramide-enriched membrane platforms" 280 : 26256-26262, 2005

22 Fung TS, "Regulation of stress responses and translational control by coronavirus" 8 : 184-, 2016

23 Kawase M, "Protease-mediated entry via the endosome of human coronavirus 229E" 83 : 712-721, 2009

24 Fung TS, "Post-translational modifications of coronavirus proteins : roles and function" 13 : 405-430, 2018

25 Wei X, "PEDV enters cells through clathrin-, caveolae-, and lipid raft-mediated endocytosis and traffics via the endo-/lysosome pathway" 51 : 10-, 2020

26 den Boon JA, "Organelle-like membrane compartmentalization of positive-strand RNA virus replication factories" 64 : 241-256, 2010

27 Tang X, "On the origin and continuing evolution of SARS-CoV-2" 7 : 1012-1023, 2020

28 Baglivo M, "Natural small molecules as inhibitors of coronavirus lipid-dependent attachment to host cells: a possible strategy for reducing SARS-COV-2 infectivity?" 91 : 161-164, 2020

29 Choi KS, "Murine coronavirus requires lipid rafts for virus entry and cell-cell fusion but not for virus release" 79 : 9862-9871, 2005

30 Heaton NS, "Multifaceted roles for lipids in viral infection" 19 : 368-375, 2011

31 Spiga O, "Molecular modelling of S1 and S2subunits of SARS coronavirus spike glycoprotein" 310 : 78-83, 2003

32 Memish ZA, "Middle East respiratory syndrome coronavirus in bats, Saudi Arabia" 19 : 1819-1823, 2013

33 Romero-Brey I, "Membranous replication factories induced by plus-strand RNA viruses" 6 : 2826-2857, 2014

34 Simons K, "Membrane organization and lipid rafts" 3 : a004697-, 2011

35 Belouzard S, "Mechanisms of coronavirus cell entry mediated by the viral spike protein" 4 : 1011-1033, 2012

36 Nicora CD, "MERS coronavirus: methods and protocols" Humana 173-194, 2020

37 Lu Y, "Lipid rafts are involved in SARS-CoV entry into Vero E6 cells" 369 : 344-349, 2008

38 Barman S, "Lipid raft disruption by cholesterol depletion enhances influenza A virus budding from MDCK cells" 81 : 12169-12178, 2007

39 Martin-Acebes MA, "Lipid metabolism" InTech 291-322, 2013

40 Mazzon M, "Lipid interactions during virus entry and infection" 16 : 1493-1502, 2014

41 Villanueva RA, "Interactions between virus proteins and host cell membranes during the viral life cycle" 245 : 171-244, 2005

42 Muller C, "Inhibition of cytosolic phospholipase A2α impairs an early step of coronavirus replication in cell culture" 92 : e01463-17, 2018

43 Dawood AA, "Inhibition of N-linked glycosylation by tunicamycin may contribute to the treatment of SARS-CoV-2" 149 : 104586-, 2020

44 Glende J, "Importance of cholesterol-rich membrane microdomains in the interaction of the S protein of SARS-coronavirus with the cellular receptor angiotensinconverting enzyme 2" 381 : 215-221, 2008

45 Han Y, "Identification of diverse bat alphacoronaviruses and betacoronaviruses in China provides new insights into the evolution and origin of coronavirus-related diseases" 10 : 1900-, 2019

46 Snyers L, "Human rhinovirus type 2 is internalized by clathrin-mediated endocytosis" 77 : 5360-5369, 2003

47 Nomura R, "Human coronavirus 229E binds to CD13 in rafts and enters the cell through caveolae" 78 : 8701-8708, 2004

48 Grassi G, "Hepatitis C virus relies on lipoproteins for its life cycle" 22 : 1953-1965, 2016

49 Verma SP, "HIV : a raft-targeting approach for prevention and therapy using plant-derived compounds(review)" 10 : 51-59, 2009

50 Takahashi T, "Function of membrane rafts in viral lifecycles and host cellular response" 2011 : 245090-, 2011

51 Le Poder S, "Feline and canine coronaviruses : common genetic and pathobiological features" 2011 : 609465-, 2011

52 Cascella M, "Features, evaluation, and treatment of coronavirus (COVID-19)" StatPearls Publishing

53 Oudshoorn D, "Expression and cleavage of Middle East respiratory syndrome coronavirus nsp3-4polyprotein induce the formation of double-membrane vesicles that mimic those associated with coronaviral RNA replication" 8 : e01658-17, 2017

54 Owczarek K, "Early events during human coronavirus OC43 entry to the cell" 8 : 7124-, 2018

55 den Boon JA, "Cytoplasmic viral replication complexes" 8 : 77-85, 2010

56 Orlowski S, "Coronaviruses, cholesterol and statins: involvement and application for COVID-19" 189 : 51-64, 2021

57 Fehr AR, "Coronaviruses : an overview of their replication and pathogenesis" 1282 : 1-23, 2015

58 Fecchi K, "Coronavirus interplay with lipid rafts and autophagy unveils promising therapeutic targets" 11 : 1821-, 2020

59 World Health Organization, "Coronavirus disease (COVID-19)weekly epidemiological update and weekly operational update" WHO

60 Burkard C, "Coronavirus cell entry occurs through the endo-/lysosomal pathway in a proteolysis-dependent manner" 10 : e1004502-, 2014

61 Dhama K, "Coronavirus Disease 2019-COVID-19" 33 : e00028-20, 2020

62 Poortahmasebi V, "Clinical performance of RT-PCR and chest CT scan for COVID-19 diagnosis; a systematic review" 2020

63 Van Hamme E, "Clathrin-and caveolae-independent entry of feline infectious peritonitis virus in monocytes depends on dynamin" 2008

64 Bajimaya S, "Cholesterol is required for stability and infectivity of influenza A and respiratory syncytial viruses" 510 : 234-241, 2017

65 Yin J, "Cholesterol is important for a post-adsorption step in the entry process of transmissible gastroenteritis virus" 88 : 311-316, 2010

66 Yan B, "Characterization of the lipidomic profile of human coronavirus-infected cells : implications for lipid metabolism remodeling upon coronavirus replication" 11 : 73-, 2019

67 Nagy PD, "Building viral replication organelles : close encounters of the membrane types" 12 : e1005912-, 2016

68 Mobini Kesheh M, "Bioinformatic HLA studies in the context of SARS-CoV-2 pandemic and review on association of HLA alleles with preexisting medical conditions" 2021 : 6693909-, 2021

69 Leneva I, "Antiviral activity of umifenovir in vitro against a broad spectrum of coronaviruses, including the novel SARS-CoV-2 virus" 13 : 1665-, 2021

70 Kuo L, "Analyses of coronavirus assembly interactions with interspecies membrane and nucleocapsid protein chimeras" 90 : 4357-4368, 2016

71 Mina Mobini Kesheh, "An overview on the seven pathogenic human coronaviruses" Wiley 2021

72 Millan-Onate J, "A new emerging zoonotic virus of concern : the 2019 novel Coronavirus(SARS CoV-2)" 24 : 187-192, 2020

73 Wu F, "A new coronavirus associated with human respiratory disease in China" 579 : 265-269, 2020